<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ETHAVERINE HYDROCHLORIDE</span><br/>(e'tha-ve-rine)<br/><span class="topboxtradename">Ethaquin, </span><span class="topboxtradename">Ethatab, </span><span class="topboxtradename">Ethavex-100, </span><span class="topboxtradename">Isovex<br/></span><b>Classifications:</b> <span class="classification">cardiovascular agent</span>; <span class="classification">non-nitrate vasodilator</span><br/><b>Prototype: </b>Hydralazine HCl<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>100 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Alkaloid prepared synthetically from opium with no narcotic properties. Directly relaxes all smooth muscles, especially when
         they have been spasmodically contracted.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Action is especially pronounced when spasm is present on coronary, cerebral, pulmonary, and peripheral arteries. Acts directly
         on myocardium like quinidine; depresses conduction and irritability, and prolongs refractory period.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Primarily for peripheral and cerebral vascular insufficiency associated with arterial spasm; also a smooth muscle spasmolytic
         in spastic conditions of the GI and GU tracts.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Complete atrioventricular dissociation (AV heart block) and severe liver disease; pregnancy (category C).</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Patients with glaucoma; myocardial depression; lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Peripheral and Cerebral Vascular Insufficiency</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 100 mg t.i.d., may increase up to 200 mg t.i.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Monitor heart rate (apical pulse for 1 full minute) and BP; if significant changes occur (e.g., hypotension, arrhythmias),
            withhold drug and notify physician.
         </li>
<li>Preserve in a tightly covered, light-resistant container.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Vertigo, <span class="speceff-common">headache, drowsiness.</span> <span class="typehead">CV:</span> <span class="speceff-common">Hypotension,</span> arrhythmias. <span class="typehead">GI:</span> Nausea, anorexia, abdominal distress, dry throat. <span class="typehead">Other:</span> Malaise, <span class="speceff-common">flushing,</span> sweating, lassitude, <span class="speceff-life">respiratory depression</span>. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May decrease <b>levodopa</b> effectiveness; <b>morphine</b> may antagonize smooth muscle relaxation effect of ethaverine. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Peak:</span> 1Â–2 h. <span class="typehead">Duration:</span> 6 h regular tablets. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted in urine chiefly as metabolites. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor apical pulse for changes in rate and rhythm routinely; drug may cause cardiac arrhythmias.</li>
<li>Monitor BP for hypotension, and respiration rate for respiratory depression. Promptly report marked changes to physician.</li>
<li>Lab tests: Periodic liver function and blood chemistry; hepatotoxicity (thought to be a hypersensitivity reaction) is reversible
            with prompt drug withdrawal.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not drive or engage in other potentially hazardous activities until response to drug is known.</li>
<li>Avoid alcohol; it may increase drowsiness and dizziness.</li>
<li>Notify physician if jaundice or skin rash appear. Liver function tests may be indicated.</li>
<li>Be aware that drug may cause flushing, headache, and diaphoresis; notify physician if symptoms are pronounced.</li>
<li>Notify physician if GI distress develops and persists.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>